The evolution of treatment options for patients with relapsed/refractory multiple myeloma
Agenda
Learning objective:
After participating in this webinar, viewers should be able to:
- Updates from ASH 2020 on the management of patients with relapsed / refractory MM
Faculty:
- Michel Delforge (Belgium)
- Maria-Victoria Mateos (Spain)
More Info
63 Minutes
EM-49327 - Date of preparation: January 2021